Differential diagnoses: How to determine cause of visual field loss

Article

Management decisions for a patient who presents with a visual field defect should never be made before considering a host of other etiologies that can masquerade as glaucoma by the type of visual field loss.

New York-Management decisions for a patient who presents with a visual field defect (VFD) should never be made before considering a host of other etiologies that can masquerade as glaucoma by the type of visual field loss (VFL), said Sherry J. Bass, OD, FAAO, at International Vision Expo East.

Consider big picture

VFL associated with glaucoma presents initially as paracentral defects with progression to nasal step defects, arcuate and Bjerrum defects, altitudinal defects, and ultimately, if the disease is not controlled, peripheral field constriction. For each of these types of defects, there are different etiologies to consider as an alternative diagnosis.

Non-glaucomatous etiologies of paracentral field loss include hereditary macular disease, such as Stargardt macular degeneration and cone dystrophy, and optic pits. Superior paracentral VFLs can be found in patients with a hereditary macular disease as a result of their typical use of superior eccentric fixation to achieve better vision.

In patients with an optic pit, usually located at the inferior temporal border of the optic nerve head, paracentral field loss is secondary to loss of the retinal nerve fiber layer between the macula and optic nerve that can exist in this condition, Dr. Bass explained.

Nasal field defects are also a sign of early glaucoma but can alternatively be caused by optic disc drusen. Diagnosis of optic disc drusen may be challenged by the fact that the lesions may be buried in younger patients.

"The finding of an optic nerve head with blurry disc borders and no cupping in a patient with a nasal field defect should suggest the diagnosis of optic nerve drusen," Dr. Bass said.

"Further evaluation should include B-scan ultrasonography," she continued. "However, this imaging is only effective for identifying drusen that are calcified, which includes about 50% of disc drusen."

Recent Videos
Jessica Steen, OD, FAAO, Dipl-ABO, discussed ophthalmic considerations for patients undergoing treatment with antibody drug conjugates for gynecologic cancers at this year's conference.
A. Paul Chous, MA, OD, FAAO, details a presentation on this year's updates on diabetes given at this year's Academy meeting
Sherrol Reynolds, OD, FAAO, said that multimodel imaging has been a game changer in assessing the choroidal function and structural changes in various disease conditions.
Susan Gromacki, OD, FAAO, FSLS, provides key takeaways from this year's American Academy of Optometry symposium genetics and the cornea.
Roya Attar gives an overview of her presentation, "Decoding the Retina: The Value of Genetic Testing In Inherited Disorders," presented with Mohammad Rafieetary, OD, FAAO, FORS, ABO, ABCMO.
Ian Ben Gaddie, OD, FAAO, outlines key findings from a recent study evaluating lotilaner in patients with Demodex blepharitis and meibomian gland dysfunction.
Clark Chang, OD, MSA, MSc, FAAO, discussed the complexities of diagnosing keratoconus in his Rapid Fire presentation given at the American Academy of Optometry 2024 meeting.
Mohammad Rafieetary, OD, FAAO, FORS, Dipl ABO, ABCMO, details the ease of genetic testing when diagnosing patients or reassessing a patient's diagnosis.
Gromacki, OD, FAAO, FSLS, emphasizes that corneal GP lenses remain an important part of a contact lens specialist's armamentarium
Mohammad Rafieetary, OD, FAAO, FORS, Dipl ABO, ABCMO, discusses diagnostic confusion that can be encountered when identifying macular edema in patients.
© 2024 MJH Life Sciences

All rights reserved.